scispace - formally typeset
M

Mauro Castellarin

Researcher at University of Pennsylvania

Publications -  20
Citations -  2703

Mauro Castellarin is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Islet & Regulatory sequence. The author has an hindex of 16, co-authored 20 publications receiving 2246 citations. Previous affiliations of Mauro Castellarin include BC Cancer Agency & McGill University Health Centre.

Papers
More filters
Journal ArticleDOI

Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

TL;DR: Overabundance of Fusobacterium sequences in tumor versus matched normal control tissue is verified by quantitative PCR analysis from a total of 99 subjects, and a positive association with lymph node metastasis is observed.
Journal ArticleDOI

Derivation of HLA types from shotgun sequence datasets

TL;DR: HLAminer, a computational method for identifying HLA alleles directly from shotgun sequence datasets that circumvents the additional time and cost of generating HLA-specific data and capitalizes on the increasing accessibility and affordability of massively parallel sequencing.
Journal ArticleDOI

Sequence analysis of T-cell repertoires in health and disease

TL;DR: T-cell antigen receptor (TCR) variability enables the cellular immune system to discriminate between self and non-self as mentioned in this paper, and T-cell repertoire sequencing is still in its infancy, however, it is expected that maturation of the field will involve the introduction of improved, standardized tools for data handling, deposition and statistical analysis, as well as the emergence of new and equivalently large-scale technologies for Tcell functional analysis and antigen discovery.
Journal ArticleDOI

Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer

TL;DR: The findings reveal the limitations of spontaneous tumor immunity in the setting of standard treatments and suggest a high degree of ignorance of tumor mutations that could potentially be reversed by immunotherapy.

Sequence analysis of T-cell repertoires in health

TL;DR: This nascent field and TCR-seq methodology, which involves the use of next generation sequencing platforms to generate large numbers of short DNA sequences covering key regions of the TCR coding sequence, is introduced and discusses recent insights into healthy and diseased TCR repertoires.